News >

Oncology Fellow Discusses Immunotherapy Developments in Squamous NSCLC

Jessica Hergert
Published: Wednesday, Oct 30, 2019

Pradnya D. Patil, MD, FACP, hematology and oncology fellow at the Taussig Cancer Institute, Cleveland Clinic

Pradnya D. Patil, MD, FACP

Following the transformation of frontline treatment for patients with advanced squamous non–small cell lung cancer (NSCLC) to include immunotherapy, research efforts should now focus on identifying biomarkers to predict response, as well as determining mechanisms of resistance, explained Pradnya D. Patil, MD, FACP.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication